DCN and urinary bladder carcinoma: Significantly, decorin exposure of bladder cancer cells considerably reduced IGF-I-induced IGF-IR and caveolin-1 colocalization, suggesting that decorin may affect either IGF-IR internalization or divert the receptor into a different endocytic compartment (77).